3.98
price up icon150.31%   2.39
pre-market  시장 영업 전:  3.00   -0.98   -24.62%
loading
전일 마감가:
$1.59
열려 있는:
$1.58
하루 거래량:
32.47M
Relative Volume:
44.81
시가총액:
$225.27M
수익:
-
순이익/손실:
$-131.52M
주가수익비율:
-2.236
EPS:
-1.78
순현금흐름:
$-107.56M
1주 성능:
+132.75%
1개월 성능:
+170.75%
6개월 성능:
+348.50%
1년 성능:
+220.97%
1일 변동 폭
Value
$1.43
$4.22
1주일 범위
Value
$1.43
$4.22
52주 변동 폭
Value
$0.6101
$4.22

Prelude Therapeutics Inc Stock (PRLD) Company Profile

Name
명칭
Prelude Therapeutics Inc
Name
전화
(302) 467-1280
Name
주소
175 INNOVATION BOULEVARD, WILMINGTON
Name
직원
131
Name
트위터
Name
다음 수익 날짜
2024-10-30
Name
최신 SEC 제출 서류
Name
PRLD's Discussions on Twitter

PRLD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PRLD
Prelude Therapeutics Inc
3.98 89.99M 0 -131.52M -107.56M -1.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Prelude Therapeutics Inc Stock (PRLD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-09-19 업그레이드 H.C. Wainwright Neutral → Buy
2024-06-20 다운그레이드 Barclays Equal Weight → Underweight
2024-03-13 개시 JMP Securities Mkt Outperform
2024-02-20 다운그레이드 H.C. Wainwright Buy → Neutral
2023-12-19 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2022-11-21 다운그레이드 BofA Securities Neutral → Underperform
2022-09-09 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2022-07-29 개시 Jefferies Buy
2022-03-15 다운그레이드 BofA Securities Buy → Neutral
2022-02-28 다운그레이드 Barclays Overweight → Equal Weight
2021-10-08 업그레이드 Morgan Stanley Equal-Weight → Overweight
2021-07-27 업그레이드 BofA Securities Neutral → Buy
2021-04-26 개시 H.C. Wainwright Buy
2021-03-09 개시 Barclays Overweight
2020-11-20 다운그레이드 BofA Securities Buy → Neutral
2020-10-20 개시 BofA Securities Buy
2020-10-20 개시 Goldman Neutral
2020-10-20 개시 Morgan Stanley Equal-Weight
모두보기

Prelude Therapeutics Inc 주식(PRLD)의 최신 뉴스

pulisher
02:45 AM

Prelude Therapeutics (PRLD) Projected to Post Earnings on Wednesday - Defense World

02:45 AM
pulisher
02:24 AM

Prelude Therapeutics Spikes: Can The Pipeline Keep Up? - RTTNews

02:24 AM
pulisher
01:35 AM

Prelude Therapeutics (NASDAQ:PRLD) and CytoDyn (OTCMKTS:CYDY) Financial Analysis - Defense World

01:35 AM
pulisher
Nov 03, 2025

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.51% - Investing.com

Nov 03, 2025
pulisher
Nov 03, 2025

Prelude Therapeutics (PRLD) to Present Preclinical Findings at A - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

Can Prelude Therapeutics Incorporated stock hit analyst price targetsDay Trade & Real-Time Price Movement Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Prelude Therapeutics Incorporated stock ready for a breakoutQuarterly Trade Review & High Accuracy Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting - Yahoo Finance

Nov 03, 2025
pulisher
Nov 03, 2025

Pattern recognition hints at Prelude Therapeutics Incorporated upsideJuly 2025 Market Mood & Stepwise Swing Trade Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What to do if you’re stuck in Prelude Therapeutics IncorporatedJuly 2025 Weekly Recap & Safe Swing Trade Setups - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What institutional flow reveals about Prelude Therapeutics Incorporated2025 Trading Recap & Daily Profit Maximizing Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Prelude Therapeutics Incorporated stock reacts to oil pricesJuly 2025 Movers & High Accuracy Swing Entry Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Prelude Therapeutics Incorporated stock a defensive play in 2025Quarterly Portfolio Summary & Weekly Setup with High ROI Potential - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Volume spikes in Prelude Therapeutics Incorporated stock – what they meanJuly 2025 Recap & Technical Pattern Based Buy Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Prelude Therapeutics Incorporated stock deliver shareholder valueJuly 2025 Retail & Daily Oversold Bounce Ideas - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Can Prelude Therapeutics Incorporated stock maintain operating marginsJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Prelude Therapeutics Incorporated stock supported by strong fundamentalsPortfolio Performance Report & High Return Trade Guides - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Prelude Therapeutics Incorporated stock supported by innovation pipelineBear Alert & AI Enhanced Trade Execution Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Prelude Therapeutics Shares Surge on Analyst Optimism and Upcoming Earnings - AD HOC NEWS

Nov 02, 2025
pulisher
Nov 02, 2025

Prelude Therapeutics Incorporat (PRLD) stock forecast and price target - Yahoo! Finance UK

Nov 02, 2025
pulisher
Nov 02, 2025

What sentiment indicators say about Prelude Therapeutics Incorporated stockWatch List & Verified Technical Trade Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Using flow based indicators on Prelude Therapeutics IncorporatedDip Buying & Safe Entry Zone Tips - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

How to build a custom watchlist for Prelude Therapeutics Incorporated2025 Investor Takeaways & Weekly Momentum Picks - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Can Prelude Therapeutics Incorporated stock sustain free cash flow growthWeekly Profit Report & Long-Term Safe Return Strategies - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Prelude Therapeutics Inc expected to post a loss of 37 cents a shareEarnings Preview - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

What machine learning models say about Prelude Therapeutics IncorporatedTrend Reversal & Reliable Trade Execution Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Exit strategy if you’re trapped in Prelude Therapeutics IncorporatedJuly 2025 Action & Risk Controlled Swing Trade Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How Prelude Therapeutics Incorporated stock performs in interest rate cyclesInflation Watch & Free Expert Verified Stock Movement Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Real time alert setup for Prelude Therapeutics Incorporated performanceInsider Selling & Free Daily Entry Point Trade Alerts - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Prelude Therapeutics Incorporated (PRLD) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Oct 30, 2025
pulisher
Oct 30, 2025

Prelude Therapeutics Incorporated (PRLD) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025
pulisher
Oct 30, 2025

Real time pattern detection on Prelude Therapeutics Incorporated stock2025 Technical Overview & Low Drawdown Investment Strategies - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

How moving averages guide Prelude Therapeutics Incorporated trading2025 Key Highlights & AI Forecast for Swing Trade Picks - newser.com

Oct 30, 2025

Prelude Therapeutics Inc (PRLD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
자본화:     |  볼륨(24시간):